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AKTIVITI ANTI-INFLAMASI DAN ANALGESIA EKSTRAK BUAH 
GARCINIA ATROVIRIDIS  
 
ABSTRAK 
 
Garcinia atroviridis (GA) merupakan herba perubatan boleh dimakan yang 
digunakan secara tradisional dalam merawat sakit telinga, perit tekak, batuk, 
kelemumur, bengkak abdomen dan rawatan selepas bersalin. Dalam kajian ini, 
aktiviti anti-inflamasi dan analgesia berpandukan pengekstrakan dan fraksinasi buah 
GA telah dilakukan dalam percubaan untuk mengenalpasti agen anti-inflamasi dan 
analgesia yang lebih poten dan mempunyai kurang kesan sampingan. Buah GA 
dihiris, dikeringkan, dikisar dan diekstrak secara bersiri dengan petroleum eter, 
kloroform, metanol dan air melalui kaedah maserasi. Ekstrak dikeringkan di bawah 
tekanan terturun dan kemudian dibekukering. Hasil ekstrak buah GA adalah 1.45 %, 
0.89%, 21.24% dan 7.99% bagi ekstrak petroleum eter (PE), kloroform (CE), 
metanol (ME) dan air (WE), masing-masing. Aktiviti anti-inflamasi bagi ekstrak-
ekstrak dikaji menggunakan model tapak kaki belakang tikus aruhan karagenan. 
Didapati bahawa pemberian oral ME pada dos 500 dan 1000 mg/kg merencat edema 
kaki belakang tikus secara signifikan. ME kemudiannya difraksikan kepada fraksi 
klorofom (CF), fraksi etil asetat (EAF), fraksi n-butanol (nBF) dan fraksi air (WF). 
Antara empat fraksi, didapati WF memberikan kesan yang paling ketara dalam 
merencatkan pertumbuhan edema. Aktiviti anti-inflamasi bagi WF terus dikaji 
menggunakan kapas pelet granuloma dalam tikus, model inflamasi sub-kronik. WF 
pada (125, 250 and 500 mg/kg) merencat pembentukan granuloma (p<0.001). 
Analisis cytokine dalam darah menunjukkan paras TNF-α dan IL-1 dalam tikus yang 
xvii 
 
dirawat secara oral dengan WF adalah lebih rendah secara signifikan berbanding 
kumpulan kawalan.  Aktiviti analgesia bagi pemberian ekstrak secara oral dikaji 
menggunakan ujian plat panas dan "writhings" teraruh asid asetik terhadap tikus. 
Dalam ujian plat panas, tiada ekstrak GA yang meningkatkan masa tindakbalas tikus 
terhadap haba secara signifikan. Namun begitu, pemberian PE, CE dan ME (500 
mg/kg) merencatkan tindakbalas "writhings" secara signifikan (p<0.001). Ini 
mencadangkan bahawa tiga ekstrak memiliki aktiviti analgesia sama dengan non-
steroidal anti-inflammatory drugs (NSAIDs). Memandangkan ME menunjukkan 
aktiviti analgesia yang tertinggi, ia difraksikan kepada fraksi kloroform (CF), fraksi 
etil asetat (EAF), fraksi n-butanol (nBF) dan fraksi air (WF). WF telah dijumpai 
sebagai yang paling ketara dalam merencat "writhings". Penglibatan cyclooygenase 
(COX-1 dan COX-2) dan cytokine (TNF-α dan IL-1) dalam mekanisma anti-
inflamasi bagi WF telah dikaji. WF (200 µg/ml) telah dijumpai merencat kedua-dua 
COX-1 dan COX-2. WF pada kepekatan melebihi 100 µg/ml telah dijumpai sebagai 
sitotosik kepada sel-sel U937. Oleh itu, WF pada kepekatan yang lebih rendah (50 
µg/ml dan 25 µg/ml) telah digunakan bagi mengkaji kesan WF terhadap pelepasan 
TNF-α dan IL-1 oleh sel-sel U937. WF telah dijumpai merencat pelepasan TNF-α 
dan IL-1. Ini mencadangkan bahawa mekanisma tindakan anti-inflamasi bagi WF 
antaranya adalah dengan merencatkan COX-1, COX-2, TNF-α dan IL-1. Saringan 
fitokimia menunjukkan kehadiran flavanoid, alkaloid dan saponin dalam WF. 
Analisa High Performance Liquid Chromatography (HPLC) menunjukkan kehadiran 
hydroxycitric acid dan kumpulan laktonnya dalam ME dan WF bagi ekstrak buah G. 
atroviridis. 
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ANTI-INFLAMMATORY AND ANALGESIC ACTIVITIES OF GARCINIA 
ATROVIRIDIS FRUIT EXTRACTS  
 
ABSTRACT 
 
Garcinia atroviridis (GA) is an edible medicinal herb traditionally used for the 
treatment of earache, throat irritation, cough, dandruff, swollen abdomen and 
postpartum medication. In the present study, the anti-inflammatory and analgesics 
activity-guided extraction and fractionation of GA fruit were carried out in an 
attempt to identify anti-inflammatory and analgesic agents which are more potent 
and with less side effects. The GA fruits were sliced, dried, pulverized and serially 
extracted with petroleum ether, chloroform, methanol and water using maceration 
method. The extracts were dried under reduced pressure and freeze-dried. The 
extraction yield were 1.45%, 0.89%, 21.24% and 7.99% petroleum ether (PE), 
chloroform (CE), methanol (ME) and water (WE) extracts, respectively. The anti-
inflammatory activity of the extracts was studied using carrageenan-induced hind 
paw oedema in rat. Only administered ME at doses of 500 and 1000 mg/kg were 
found significantly inhibited the hind paw oedema. ME was then fractionated into 
chloroform (CF), ethyl acetate (EAF), n-butanol (nBF) and water (WF) fractions. 
Among these four fractions, WF was found to be the most potent in inhibiting the 
oedema formation. The anti-inflammatory activity of WF was further studied in 
cotton pellet-induced granuloma in rats, a sub-chronic model of inflammation. WF 
(125, 250 and 500 mg/kg) significantly inhibited the granuloma formation (p<0.001). 
Blood cytokine analysis showed that the level of TNF-α and IL-1 in the WF orally 
treated rats were significantly lower than the control group. The analgesic activity of 
xix 
 
the orally administered extracts was studied using hot plate and acetic acid-induced 
writhings tests in mice. In the hot plate test, none of the GA extracts significantly 
increased the mice response time to heat. However, administration of PE, CE and 
ME (500 mg/kg) significantly inhibited writhings response (p<0.001). It suggests 
that the three extracts possess analgesic activity similar to non-steroidal anti-
inflammatory drugs (NSAIDs). Since the ME showed the highest analgesic activity, 
it was fractionated to chloroform (CF), ethyl acetate (EAF), n-butanol (nBF) and 
water (WF) fractions. WF was found to be the most potent in inhibiting the 
writhings. The involvement of cyclooxygenases (COX-1 and COX-2) and cytokines 
(TNF-α and IL-1) in the anti-inflammatory mechanism of WF were studied. WF (200 
µg/ml) was found to inhibit both COX-1 and COX-2. WF at concentrations above 
100 µg/ml was found to be cytotoxic to U937 cells. Therefore, the lower 
concentrations of WF (50 µg/ml and 25 µg/ml) were used to study the effect of WF 
on TNF-α and IL-1 released by U937 cells. WF was found to inhibit the released of 
TNF-α and IL-1. It suggests that the anti-inflammatory mechanism of actions of WF 
among others are by inhibiting COX-1, COX-2, TNF-α and IL-1. Phytochemical 
screening indicated the presence of flavonoids, alkaloids and saponins in WF. High 
Performance Liquid Chromatography (HPLC) analysis revealed the presence of 
hydroxycitric acid and its lactone in ME and WF of G. atroviridis fruit extracts. 
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CHAPTER ONE 
INTRODUCTION 
 
 
 
1.1 The plant (Garcinia atroviridis) 
1.1.1 Botanical aspects 
Scientific name : Garcinia atroviridis Griffith ex T. Anders 
Common name : Asam keping or kayu gelugor 
Local name : Gelugor (Malay), som khaek (Thailand) 
Family : Clusiaceae / Guttiferae 
Garcinia genus has been used as medicinal herb for many centuries in tropical region 
of Asia, Africa and Polynesia (Whitmore, 1973). It was reported beneficial for the 
treatment of obesity and for control of dietary intake (Amran et al., 2009, 
Roongpisuthipong et al., 2007). Garcinia atroviridis one of herbs from genus 
Garcinia is an endemic species in Peninsular Malaysia with a medium-sized fruit 
tree, which may be found growing wild or cultivated (Mackeen et al., 2002, Permana 
et al., 2001). 
 
1.1.2 Plant description 
G. atroviridis is a medium-sized tree that grows up to 15-20m height (Plate 1.1). It 
has a long trunk with smooth pale grey bark and drooping branches. The leaves are 
dark green when mature, glossy, decussate arrangement and narrowly oblong, late 
tapering to base with a pointed tip and upturned edges. The flowers are dark red. The 
fruits are globose and around 7-10cm in diameter, pumpkin-like features, borne 
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singly on twig ends (Plate 1.2). The fruit contains flattened seeds which are 1.5cm 
long, surrounded by bright orange pulp (arillode). Young green fruits will turn into 
bright yellow when ripe (Subhadrabandhu, 2001). The morphological characteristics 
of Garcinia atroviridis spp. have been summarized in Table 1.1. 
Table 1.1 Morphological characteristics of G. atroviridis (Te-chato et al., 2000). 
Part Morphological characteristics 
Flowering (month of the year) July-September 
Latex color Yellow 
Petal colour Purple 
Stigma Sessile 
Stigma surface Corrugated 
Stigma lobe 80% diameter 
Stamen mass Round 
Female flower Staminodes 
Pollen viability 3-5% 
Fruit shape Globose 
Fruit color Green 
Fruit surface Wrinkled 
Fruit flavor Sour 
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                Plate 1.1 G. atroviridis tree 
 
 
                          Plate 1.2 Fruit of G. atroviridis 
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1.1.3 Plant habitat and cultivation 
G. atroviridis is a native plant of Peninsular Malaysia, Thailand, Myanmar and India. 
It has been found wild growing as individual trees in the forest of high rainfall areas 
especially in the northern part of Peninsular Malaysia and southern Thailand and 
sometimes cultivated as a home garden plant (Subhadrabandhu, 2001, Burkill et al., 
1966).  
The reproductive behaviour of G. atroviridis was reported to be facultative apomixis 
which give the advantage to the female plants to produce the progeny successfully 
even in a male-free population (Pangsuban et al., 2009). It is gynodioecious plant 
which commonly planted by propagation of germinating seeds. It takes 6-7 years for 
the tree to attained maximum fruit yield and 11-12 weeks after fruit setting for the 
fruit to became ripe. Fruits are produced by female trees. However, sometimes 
hermaphrodite trees also bear few fruits or have no fruit-set (Pangsuban et al., 2009, 
Pangsuban et al., 2007). It is not yet proof scientifically, but trees that grown from 
seedling are observed to result in more male than female trees. Therefore, plants of 
desired sex which can bear fruits within 4-5 years of grafting may be produced by 
grafting or inarching bud wood of known sex onto seedling (Subhadrabandhu, 2001). 
 
1.1.4 Phytochemical studies on G. atroviridis 
Many parts of G. atroviridis have been studied phytochemically and reported to have 
wide range of compounds (Table 1.2). The compounds isolated belong to xanthone, 
organic acid, flavonoids and volatile compounds. 
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Table 1.2 Chemical constituents of G. atroviridis. 
Parts of Plant Chemical constituents 
Root 
Atrovirinone and Atrovirisidone (Permana et al., 2001) 
Atrovirisidone B,  Aringenin and 3'8"-binaringenin (Permana et al., 2005) 
4-methyldroatrovirinone, Morelloflavone, 7-O-β glucopyranoside,  Fukugiside  and 14-cis-docosenoic acid 
(Permana et al., 2003) 
Stem Bark Atroviridin (xanthone) (Kosin et al., 1998)  
Fruit 
(-)-β-Caryophyllene, β-Caryophyllene alcohol (β-Caryolanol), α-humulene, Humulol, Ginsenol (Tan et al., 2012) 
2-(butoxycarbonylmethyl)-3-butoxycarbonyl-2-hydroxy-3-propanolide and 1′,1′′-dibutyl methyl hydroxycitrate 
(Mackeen et al., 2002) 
Flavonoids (myricetin, quercetin & luteolin) (Miean and Mohamed, 2001) 
Organic acids (citric, hydroxycitric, tartaric, malic and ascorbic acid) (Amran et al., 2010, Amran et al., 2009, 
Zainal Abidin, 2005) 
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1.1.5 Pharmacological activities of G. atroviridis 
G. atroviridis is popularly used as folklore medicine for the treatment of earache, 
postpartum medication, throat irritation, cough, dandruff, stomachache associated with 
pregnancy, swollen abdomen and some may mix the fruit extract with vinegar lotion for 
topical application upon the abdomen of a woman after childbirth (Ahmad, 2010, 
Grosvenor et al., 1995, Burkill et al., 1996). The pharmacological activities of G. 
atroviridis have been studied previously are shown on Table 1.3. 
Table 1.3 Pharmacological activities of G. atroviridis. 
Parts of 
Plant Pharmacological activities 
Fruit 
Improve blood circulation, expectorant, cough, laxative and 
vasodilatation (Yapwattanaphun et al., 2000)  
Reduce cholesterol in blood and dietary supplement (Amran et al., 
2009) 
Treat obesity (Roongpisuthipong et al., 2007) 
Anti-oxidant (Ikram et al., 2009) 
Anti-bacterial and anti-inflammatory (Mackeen et al., 2000) 
Anti-fungal (Mackeen et al., 2002) 
Anti-glycation (Povichit et al., 2010) 
Root Anti-microbial  and Anti-oxidant (Mackeen et al., 2000) 
Leave Anti-oxidant (Mackeen et al., 2000) 
Trunk Anti-oxidant (Mackeen et al., 2000) 
Stem Bark Anti-oxidant (Mackeen et al., 2000) 
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1.2 Inflammation 
1.2.1 Overview of Inflammation 
The mechanisms for combating the threat of infection and for promoting healing and 
restoration to the normal function in the event of injury are termed as inflammation.  It is 
the vital function when the body response for protection towards noxious stimuli 
(chemical, mechanical or pathogens) or a process of reparation, triggered by a complex 
interrelated cascade system in the body (Spector and Willoughby, 1963). There are five 
cardinal signs that indicate inflammation: heat (calor), redness (rubor), swelling (tumor), 
pain (dolor) and loss of function (functio laesa) (Ryan and Majno, 1977). Inflammation 
involves three important components; harmful stimuli such as pathogen or chemical 
irritation, sensors such as receptors on mast cells and macrophages, and mediators such 
as cytokines, histamine (H), prostaglandins (PGs) family and bradykinin (BK). The 
process of inflammation can be characterized into three phases; increased in vascular 
permeability that lead to oedema, leukocytes infiltration from blood into the tissues and 
formation of granuloma (Vogel, 2007; Tripathi, 2008).  
 
1.2.2 Acute and chronic inflammation 
Acute inflammation is normally a localized, protective response following trauma or 
infection, which can be resolved within a short period of time. It usually compromise 
two components which are innate non-adaptive response and adaptive (acquired or 
specific) immunological response (Figure 1.1). The innate response is an immediate 
response activated after infection of injury, comprises of vascular and cellular reaction, 
meanwhile adaptive immune response is highly specific defensive mechanism that only 
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starts up after the pathogen has been recognized by the innate system and normally 
involves the lymphocytes (Rang and Dale, 2007). However, inappropriate control of the 
defense mechanism during acute response or the persistent of pathogen in the body 
system may ultimately contributed to the inflammation into chronic stage. This reaction 
is slow and it could destroy tissues, thus taking longer time to resolve (Kumar et al., 
2007). 
During acute inflammation, abrupt response mediated by autacoids (e.g. eicosanoids, 
nitric oxide, kinin, serotonin and histamine)  will occur to precedes the development of  
immunity. Acute response occur in short duration, resolves within hours or days. The 
immediate response will trigger a variety of inflammatory cells to move to the injured 
tissues such as polymorphonuclear leukocytes (PMNs) (e.g. neutrophils, basophils and 
eosinophils) which are attracted by the chemoattractants released by the injured cells. 
Initially, phagocytic leukocytes known as neutrophils which prevalently available during 
acute inflammation will migrate to the inflamed site and followed by the accumulation 
of monocytes which then activated into macrophages (Serhan, 2008). Activated 
macrophages will synthesize varieties of bioactive lipids such as eicosanoids 
(prostaglandin and leukotrienes) and platelet activating factor (PAF), and also release 
pro-inflammatory cytokines notably as tumor necrosis factor-alpha (TNF-α) and 
interleukin-1 (IL-1) (Laskin and Pendino, 1995).  
The ability of the body to act briefly and rapidly towards the clearance of harmful 
stimuli by interconnected inflammatory mechanisms are very important as to avoid 
overwhelming situations. Persisted and the presence of long-lasting injury causing agent 
can be detrimental to the host. Acute inflammation can become chronic if the normal 
9 
 
healing process in acute inflammatory response is unsuccessful to ingest the toxic 
injuring causing material. Previous studies have reported, in uncontrollable situation, 
acute inflammation could turn into chronic condition by the powerful influences of most 
pro-inflammatory mediators such as prostaglandins and leukotrienes and,  various 
cytokines such as TNF-α, IL-1 and chemotactic cytokines (Langhans, 2006, Lawrence et 
al., 2002, Feghali and Wright, 1997). 
Primary chronic inflammation can occur if the responsible agent is unclear. It is the 
subsequent tissues reaction towards injury. The inflammation process may become 
exaggerated, in which often associated with the accumulation of lymphocytes, plasma 
cells and formation of granuloma from the fusion of multinucleated gigantic cells 
(MGC) (Kunkel et al., 1989). Multinucleated gigantic cells are well known to form from 
the fusion of the phagocytic leukocytes (macrophage) and plays important roles in 
physiological and pathological function (Helming and Gordon, 2007; Vignery, 2008). In 
healthy human, MGC are known as osteoclasts which are found in bone, responsible for 
bone resorption (Vaananen et al., 2000). However, as a results of chronic inflammation, 
giant cells can arise in the nonskeletal tissues due to the presence of foreign materials 
that are poorly digestible or persistent pathogens which have not been killed yet. The 
multinucleated macrophage involves in the clearance of internalized particles, apoptotic 
cells and debris (Ruibal et al., 1997). 
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                  Figure 1.1 Acute and chronic inflammation (Kumar et al., 2007).
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1.2.3 Mediators in inflammation  
The complex pathophysiological systems in the response towards injury are controlled 
by various inflammatory mediators and inflammatory cytokines, involved both in acute 
and chronic inflammation. Further details on the roles and mechanisms involved are 
discussed below. 
i)  Histamine 
As reported by Mans et al., (2008), histamine was first discovered as H substance by 
Dale and Laidlaw in 1910. In the preparations of isolated guinea pig ileum, it has shown 
the capability of producing the contraction of smooth muscle. This biogenic amine is 
stored in granules of mast cells and basophils. It was reported  that the composition of an 
imidazole ring with an ethylamine side chain on the histamine had mediated  both 
physiologic and pathologic roles played by it (Mans et al., 2008).  
Several studies have documented the implication of histamine on immune regulation 
which mediated by differential expression of histamine receptors (H1R, H2R, H3R and 
H4R) through various stimuli, which suggested the important roles of histamine 
biologically and pharmacologically (Parson and Ganellin, 2006; MacGlashan, 2003; 
Jutel et al., 2002; Schneider et al., 2002). The actions of histamine was reported to be 
depending on which receptors were being activated. The expression of H1 receptor were 
reported to increase in in vitro differentiation of monocytes into macrophages (Triggiani 
et al., 2007), while the expression of H4 receptors in human monocytes together with its 
stimulation had lead to the influx of calcium ion, results in the reduction of monocytes 
recruitment (Dijkstra et al., 2007).  
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In the early phase of inflammation, the vasoactive amine such as histamine is the major 
vasodilator in controlling the vascular activity (Crunkhorn and Meacock, 1971; Di Rosa 
et al., 1971). Histamine has been reported to produce pain and  three major 'vasoactive' 
effects; transient vasoconstriction which followed by vascular dilatation of arterioles, 
capillaries, and venules; fluctuation in blood flow (increased to decrease); and finally 
venular leakage which results in the extravasations of plasma protein due to the 
endothelial contraction (Majno and Joris, 2004). 
ii) Serotonin [5-hydroxyptryptamine (5-HT)] 
Serotonin (5-HT), is a copious neurotransmitter and neuromodulator component of 
inflammatory chemical milieu. It is normally found in normal cells that are not neurons 
and stored in granules of platelets, mast cells, central nervous system and the enteric 
neural tissues, before infiltrate the tissue damage area (Dray, 1995). Once released, the 
contribution of it to the pain injury is through the interaction of multiple receptor 
subtypes expressed by primary afferent nociceptors (Zeits et al., 2002; Pauwels, 2000). 
5-HT is one of the first mediators reported to be released after injury, and seems did not 
play any role in chronic inflammation (Majno and Joris, 2004;  Di Rosa et al., 1971). As 
implied by the name "serotonin", serum substances that increase pressure, similar with 
histamine, the vasoactive properties in serotonin increased the vascular permeability 
with a greater tendency in inducing the contraction of the vessels (Majno and Joris, 
2004). 
The role of 5-HT as pro-inflammatory mediators have been reported previously by 
numerous studies of inflammation and pain. The released of  5-HT to the inflamed site 
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as pro-inflammatory and pro-nociceptive, excite the nociceptive afferents, thus inducing 
pain and hyperalgesia (Sommer, 2004; Schmelz et al., 2003; Ernberg et al., 2000; 
Kessler et al., 1992; Sufka et al., 1992; Taiwo and Levine, 1992). The mechanisms 
behind pain and hyperalgesia induce by 5-HT are determined by the multiple 5-HT 
receptors on the afferent nociceptors. Previous study on the formalin-induced 
nociceptive behaviours and oedema had revealed the involvement of 5-HT1 and 5-HT3 
receptors in the peripheral nociception associated with acute inflammation and oedema 
formation (Doak and Sawynok, 1997). 
5-HT  plays important roles in immune system. It acts as activator of the human 
monocytes and as a preventer of apoptotic activity (Soga et al., 2007). Through multiple 
5-HT receptors subtypes, it also act as a modulator of the cytokines and chemokines 
production in LPS-primed monocytes (Dürk et al., 2005). In addition,  a study on the 
experimental serum sickness in rabbit found  that, antagonizing the activity of 5-HT 
have prevent the increased in vascular permeability, thus inhibit  the localization of 
immune complexes (Kniker and Cochrane, 1968).   
iii) Kinin-bradykinin system 
The kinin-bradykinin system is composed of the precursor of kinin; kininogens, which 
could be activated by plasma and tissue kallikreins, thus producing two vasoactive 
nonapeptide namely bradykinin (BK) and kallidin. In humans, there are two kininogens 
known as high molecular weight (HMW) and low molecular weight (LMW) kininogens 
which could be converted into bradykinin. Meanwhile, in rats, in addition to the HMW 
and LMW, there is another precursor known as T-kininogen (Oh-ishi et al., 1987; 
Okamoto and Greembaum, 1983). 
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This system is mediated through two receptors noted as B1 and B2 (Regoli et al., 1993). 
The activation of this system is important as it regulates physiological and pathological 
function such as blood pressure and inflammatory response due to its roles as 
vasodilator, which could induced oedema formation, cellular accumulation and pain 
mostly mediated by B2 receptors (Shin et al., 2002, Agostoni and Cugno, 2001, Lewis, 
1958). In addition, the B1 receptors are also reported to be involved at the chronic 
inflammation by amplifying the kinin B2 receptors (Ahluwalia and Perretti, 1999). 
 During inflammation, the kinins system acts as pro-inflammatory mediators as it could 
stimulate the synthesis of prostaglandins families (PGs and PGI2), leukotrienes, 
histamine, cytokines and platelet activating factor (PAF), thus promoting the 
inflammatory process (Stadnicki et al., 2005; Couture et al., 2001, Sharma and Mohsin, 
1990). The upregulation of both kinins B1 and B2 receptors on neutrophils and 
macrophages appears to involve the elevation of  local release of bradykinin at the site of 
inflammation. The stimulation of both receptors in macrophages induce production of 
various cytokines and inflammatory mediators (Böckmann and Paegelow, 2000). 
iv) Prostaglandins (PGs) 
Prostaglandins are lipid autocoids, or collectively called eicosanoids, generated from 
arachidonate, and universally distributed in the body. The cyclic eicosanoids play 
important roles, depend on the types of PGs, some involve in physiological maintenance 
by sustaining homeostatic function (act as autocrine and paracrine lipid mediators) and 
others involve in pathophysiological activity during inflammatory response (Tripathi, 
2008).  
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In uninflammed tissues, PGs production is maintained at lower level. However, upon 
tissue injury, dramatical change in the prostanoids profiles and increase in the levels of 
PGs could occurred, which contributes to the development of cardinal signs of acute 
inflammation prior to the emigration of leukocytes from the vessels. The infiltration of 
immune cells (e.g. leukocytes) result in more prostanoids being released at the area on 
inflamed tissues, thus involve more complex immune system function (Ricciotti and 
FitzGerald, 2011). 
Arachidonic acid is metabolized by sequential actions of prostaglandin endoperoxide 
(PGG/H) synthase or colloquially known as COX, bifunctional enzymes (COX-1 and 
COX-2) which  resulted in four series of PGs, namely, prostaglandin E2 (PGE2), 
prostacylin (PGI2), Prostaglandin D2 (PGD2) and prostaglandin Fβα (PGFβα) (Ricciotti 
and FitzGerald, 2011). Further details on the roles played by each prostanoid  are 
explained below. 
i) PGE2 
PGE2 is one of the prostanoid that elicits a wide range of biological  and 
pathophysiological functions. It regulates the immune responses, blood pressure, 
gastrointestinal integrity and fertility. It also contributes to classical signs of acute 
inflammation, which are redness and swelling that result from the increased in 
microvascular permeability due to the PGE2 augmentation of arterial dilatation and pain 
results from the action of PGE2 on the peripheral sensory neurons and on central sites 
within the spinal cord and the brain (Moriyama et al., 2005; Funk, 2001; Minami et al., 
2001). 
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PGE2 is synthesized from PGH2 by cytosolic prostaglandin E2 synthase (cPGES), which 
constitutively and abundantly expressed in cytosol of various tissues and cells and also 
synthesized by membrane prostaglandin E synthase-1 (mPGES-1), a perinuclear protein 
involved in eicosanoid and glutathione metabolism. The ability of both cPGES and 
mPGES-1 to form PGE2 require glutathione as cofactor. cPGES is only capable to 
convert COX-1 derived PGH2 to PGE2  in cells, particularly the inflammatory response 
evoke by Ca2+ stimuli (Samuelsson et al., 2007; Tanioka et al., 2000). Meanwhile, 
mPGES-1 is markedly induced by cytokines and growth factor, and functional coupling 
with COX-2 in marked preferences to COX-1 (Mancini et al., 2001, Murakami et al., 
2000, Thorén and Jakobsson, 2000). 
The PGE2 is transported through the membrane by the ATP-dependent multidrug 
resistance protein-4 or diffused across the plasma membrane (Park et al., 2006) and act 
locally through the binding of its cognate receptors, known as EP1, EP2, EP3 and EP4 
(Trebino et al., 2003). Highest affinity for binding of PGE2 goes to EP3 and EP4 which 
found to be widely distributed in the system, compared to EP1 that only available in 
restricted organs and EP2 be the least abundant of the EP receptors (Sugimoto and 
Narumiya, 2007). 
Previous study on Knockout (KO) mouse has reported the role of PGE2 as pro-
inflammatory and anti-inflammatory mediators which regulated by the EP1 receptor 
signalling that acts on peripheral sensory neurons at the site of inflammation. The four 
cardinal signs during acute inflammation and hyperalgesia also found to be mediated 
through this mechanism (Moriyama et al., 2005). On the other hands, other study has 
17 
 
reported that pain response was mediated by the EP3 receptor signaling at low doses of 
PGE2 (Minami et al., 2001).  
The ability of PGE2 to bind to different EP receptors allow the inflammatory mediator to 
modulate the functions of macrophages, dendritic cells (DC) and T and B lymphocytes 
which then  lead the dual role of PGE2 during inflammation process, as the coordinator 
of both pro-inflammatory and anti-inflammatory effects (Ricciotti and FitzGerald, 
2011). The action of PGE2-EP4 signaling as pro inflammatory was reported previously 
through the regulation in the cytokine expression of DCs which facilitated the helper T 
(TH) receptor, TH1 differentiation (Yao et al., 2009). In addition, stimulation of PGE2 
during early maturation of DCs had induced the expression of TNF super family resulted 
in the enhancement of the T cell activation (Krause et al., 2009). 
In contrast, PGE2 as anti-inflammatory was found in the previous study demonstrated by 
the roles of the prostanoids in suppressing the Th1 differentiation, B cell functions and 
allergic reactions. Besides that, PGE2 also can exert the anti-inflammatory properties on 
innate cells, such as neutrophils, monocytes, and natural killer cells (Harris et al., 2002). 
Previous study on atherosclerosis also revealed the dual roles played by PGE2, which not 
only promotes apoptotic activity of the macrophage, it also reported to suppressed early 
atherosclerosis in mice chimeric for EP4 receptor deficiency in hematopoietic cells after 
8 weeks on Western style diets containing 21% milk fat and 0.15% cholesterol. In the 
same study, PGE2-EP4 signaling of the macrophage reported to act as pro-inflammatory 
mediators by regulating the production of inflammatory cytokines such as IL-1β and IL-
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6 and monocyte chemotactic protein-1 at the early stages of atherosclerosis (Babaev et 
al., 2008). 
ii) PGI2 
PGI2 is prostanoid that regulates homeostasis process in the body especially the 
cardiovascular-related activity. It is generated through the sequential actions of COX 
and PGI2 synthase (PGIS), a cytochrome P450 superfamily specific in converting PGH2 
to PGI2 (Smith et al., 1983). It is a potent vasodilator and act as inhibitor on the 
circulating platelets, leukocytes adhesion and proliferation of vascular smooth muscle 
cells (Ricciotti and Fitzgerald, 2011), mediated by specific prostanoid receptor (IP) 
which expresses in kidney, liver, lung, platelets, heart and aorta (Smyth and FitzGerald, 
2002).  
PGI2 was also reported to be an important mediators of oedema and pain in acute 
inflammation. This prostanoid was found abundantly in the synovial fluid in human 
arthritic knee joints and peritoneal cavity fluid of mice injected with irritants such as 
acetic acid, phenylbenzoquinone and zymosan (Berkenkopf and Weichman, 1988; Higgs 
et al., 1983). In the case of PGI2 actions in the pain that accompany acute inflammation, 
previous studies have reported the role of the prostacylin receptor (IP receptor) mRNA, 
which could be present in dorsal root ganglion neurons (Oida et al., 1995) and at the 
spinal cord (Doi et al., 2002). IP receptor antagonists (e.g. RO1138452 and RO3244794) 
were shown to reduce pain responses by mediating the peripheral nociception sensitized 
by inflammatory stimuli such as acetic acid-induced writhing and pain responses in 
carrageenan-induced hyperalgesia and inflammatory arthritis (Bley et al., 2006, 
Pulichino et al., 2006, Murata et al., 1997). 
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iii) PGFβα  
PGFβα is synthesized from PGH2 via PGF synthase, and was reported to be stable 
metabolite in the form of 15-keto-dihydro-PGFβα that could be found in the peripheral 
plasma and urine in both physiological and pathophysiological conditions such as 
inflammation (Basu et al., 2007). PGFβα has been reported to play important roles in the 
arteries contraction (Nakahata et al., 2006), myocadial dysfunction (Jovanović et al., 
2006) and pain (Kunori et al., 2009). Previous in vivo and in vitro study reported that 
administration of PGFβα caused acute inflammation but the biosynthesis was inhibited 
by non-steroidal anti-inflammatory drugs (NSAIDs) (Sugimoto et al., 1997). Patients 
suffered from various arthritis disease such as rheumatoid arthritis and osteoarthritis 
were found to have elevated synthesis of this prostanoids (Basu et al, 2001). 
 
1.2.4 Cytokines in inflammation 
Cytokines are a group of secreted polypeptide derived from different types of cells, 
which involved in extensive networks in immune response, and categorized as 
pleiotropic molecules due to their functionality to elicit either local or systemic response 
in an autocrine or paracrine, rather than endocrine manner (Balkwill and Burke, 1989). 
This group can be classified into cytokines mediated by humoral responses such as IL-4, 
IL-5, IL-6, IL-7, IL-13 and cytokines mediated by cellular responses such as IL-1, IL-2, 
IL-3, IL-4, IL-7, IL-9, IL-10, IL-1β, tumor necrosis factor α and β, interferons and 
transforming growth factor-β (Feghali and Wright, 1997).  
Became the major determinants that make up the cellular infiltration and activation 
which then lead to the systemic response towards inflammation, cytokines involvement 
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during inflammation were widely studied. Some cytokines may act synergistically or 
antagonistically and some may have multiple overlapping biological  functions (Paludan, 
1998; Le and Vilcek, 1987). The presence of cytokines virtually undetectable in normal 
condition except under  pathological condition. 
Inflammation that occurred in cutaneous tissue was showed to be involved a distinct 
cytokine cascade. TNF and IL-1α and β have been extensively reported to be the 
primary cytokines involved during both acute and chronic inflammation (Alciato et al., 
2010; Yuan et al., 2010; Brooks et al., 1996; Semenzato, 1990; Hart et al., 1989). Upon 
injury, bradykinin that derived from the mast cells will stimulate the release of tumor 
necrosis factor alpha (TNF-α), which will subsequently stimulates the released of 
interlekuin-1 beta (IL-1β) and interlekuin-6 (IL-6), which in turn will promote the 
released of cyclooxygenase enzymes that play a major role in the prostaglandin 
biosynthesis (Poole et al., 1999). It was reported previously that during inflammation, 
IL-1β had played a major role as cytokine stimulus for central COX-2 expression 
(Samad et al., 2001). 
Besides that, IL-1β could be induced by both TNF-α dependent and TNF-α independent 
pathways (Woolf et al., 1997). Both TNF-α and IL-1 act as pro-inflammatory to promote 
fever by eliciting the release of histamine from the mast cells, thus increasing 
vasodilatation and vascular permeability or the action might also through the stimulation 
of PGE2 synthesis of the vascular endothelial of the hypothalamus (Dinarello et al., 
1986). As mentioned earlier, the production of cytokines was also regulated by other pro 
inflammatory mediators. Previous observation on the secretion of TNF-α and IL-1β from 
21 
 
monocyte-derived dendritic cells were found to be regulated by 5-HT through the 
stimulation of 5HTR-4 and 5HTR7 (Idzko et al., 2004). 
 
1.3 Cyclooxygenases (COX-1 and COX-2) and inflammation 
Cyclooxygenase (COX) or also known as prostaglandin endoperoxide synthases is 
enzyme that catalyzes the conversion of arachidonic acid to PGG2 to PGH2 by 
peroxidase activity. The enzyme catalysis is the initial step in the biosynthesis of PGs, 
thromboxanes and prostacyclin (Tripathi, 2008, Hamberg et al., 1975). 
COX is known to exist in two isoforms; COX-1 and COX-2. While both have the same 
active site and catalyze the same reactions, COX-1 is a constitutive isoform that involve 
in normal cellular physiologic function that lead to the production of prostacyclin which 
when released by gastric mucosa is cytoprotective (Whittle et al., 1980). On the other 
hand, COX-2 is inducible isoform which when it is induced by mitogenic stimuli 
(lipopolysaccharide, phorbol myristate acetate, cytokines) and it would plays major role 
in the biosynthesis of PGs during acute inflammation (Vane DSc et al., 1998, Kujubu et 
al., 1991, Xie et al., 1991). 
Both COX isoforms are involve in acute inflammatory response, even only COX-2 was 
found to be the dominant source of PG during the event of inflammation. Previous 
studies have reported the co-expression of both COX isoforms in the synovium and 
atherosclerotic plaque obtained from patients with rheumatoid arthritis (RA) and also 
from the circulating inflammatory cells ex vivo (Schönbeck et al., 1999; Crofford et al., 
1994). 
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Several findings have indicated the contribution of both isomers in the PGs production. 
While COX-1 isoform has been reported to be constitutively expressed in the resident 
inflammatory cells such as in LPS-mediated inflammatory response and in cellular 
differentiation (McAdam et al., 2000), COX-2-derived PGs on the other hand play dual 
roles in inflammatory process in the onset of inflammation and in the resolution process. 
The resultant inflammation observed in the paw oedema induced by carrageenan has 
been reported to be resolved within 7 days in WT mice but not in COX-2-deficient mice 
(Wallace et al., 2000). 
In another study on carrageenan-induced pleurisy in rats, the COX-2 expression were 
reported to be peaked initially at early inflammatory response, whereas COX-1 
expression remained constant. PGE2 was reported to increase to high level during this 
early phase. However, a second increase of COX-2 expression to a greater level was 
reported at later phase. This mechanism was reported to be associated with the low 
synthesis of PGE2, but with the greater generation of PGD2 and 15deoxy∆12–14 
prostaglandin J2 (5deoxy∆12–14PGJ2). Thus, from the study, it was indicated that, COX-2 
act as pro-inflammatory during the early inflammatory response, which reported to be 
dominated by the polymorphonuclear leukocytes (PMNL) for the first 12 hours, while it 
acts as anti-inflammatory during the resolution phase at 48 hours, which reported to be 
dominated by the migrating mononuclear (MN) cells that differentiated into 
macrophages (Gilroy et al., 1999). 
The inflammatory stimulus and experimental procedure used determined which COX 
isoforms responsible for the inflammation. In a case of ear inflammation studies,  the 
oedema induced by tetradecanoyl phorbol acetate (TPA) in COX-1 and COX-2 deficient 
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mice were not significantly different. In contrast, a reduction in oedema induced by 
arachidonic acid was only found in COX-1-deficient mice, but not in COX-2 deficient- 
mice (Dinchuk et al., 1995; Langenbach et al., 1995; Morham et al., 1995). 
As in different experimental model being studied, COX-1-derived PGs, particularly 
PGI2 was found to be the major contributor in the initiation and perpetuation of arthritis 
in the K/BxN serum-transfer model (Chen et al., 2008). Meanwhile, the suppression of 
the synovial inflammation and joint destruction in the collagen-induced arthritis model 
were found to be significant due to COX-2 deletion, rather than the indistinguishable 
suppression showed by the COX-1-deficient-mice when compared to the controls (Ochi 
et al., 2003; Myers et al., 2000). 
 
1.4 Non-Steroidal Anti-inflammatory Drugs (NSAIDs) 
In the early of 1970s, it was proposed that the production of prostaglandin was through 
the inhibition of the cyclooxygenase enzymes, suggesting the mechanism action of non-
steroidal anti-inflammatory drugs (NSAIDs), by blocking the PGs generation (Smith and 
Willis, 1971; Vane, 1971). Several other drugs with similar therapeutic effects as being 
anti-pyretic, anti-inflammatory and analgesic like aspirin, such as paracetamol, 
indomethacin, ibuprofen and naproxen become known as "aspirin-like drugs", and due 
to distinct mechanisms of action from glucocorticosteroids, they were also classified as 
NSAIDs (Flower, 1974). They are non-narcotic and do not depress the central nervous 
system, no dependency and are weaker analgesics (Tripathi, 2008). 
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Unlike glucocorticosteroids that inhibit the release of arachidonic acid from the 
membrane phospholipid which then indirectly reduced the production of eicosanoids 
such as prostaglandins (PGs), thromboxanes (TXs) and leukotrienes (LTs), NSAIDs in 
the other hands only inhibit cyclooxygenase (COX) pathway, production of TXs and 
prostacylin, but not lipoxygenase (LOX) pathway, the main pathway producing 
leukotrienes (Figure 1.2). NSAIDs posses numerous therapeutic indications recognized 
as being anti-inflammatory by reducing redness and swelling; anti-pyretic by reducing 
high temperature and analgesic by alleviating pain (Tripathi, 2008). 
The major mechanism of action of NSAIDs is corresponds to their potency to inhibit 
COX pathway, thus inhibit prostaglandin biosynthesis. NSAIDs such as aspirin, 
paracetamol and ibuprofen could treat acute condition such as postoperative pain, fever 
and  relieve the symptoms of upper respiratory tract infection (URTI) (Derry and Moore, 
2012; Bachert et al., 2005; Collins et al, 2000). In addition, most NSAIDs such as 
celecoxib, diclofenac, ibuprofen, ketoprofen and peroxicam generally approved to treat 
chronic health problem such as osteoarthritis and rheumatoid arthritis (Altman and 
Barthel, 2011; Zhang et al., 2008; Clemett and Goa, 2000).  
NSAIDs was reported previously to be effective in inflammation associated pain.  
However, prolong used of potent COX-1 inhibition such as aspirin, indomethacin and 
peroxicam for treatment had caused gastric mucosal damage, thus results in ulceration 
(Lanza, 1989). NSAIDs with higher selectivity against COX-2 are more favorable for 
the anti-inflammatory activity as it caused fewer side effects to the mucosal lining of 
stomach (Rodriguez and Jick, 1994). However, recent studies have also reported the 
used of COX-2 inhibitor had reduced the vascular prostacylin synthesis, thus 
